Zoledronic acid for the treatment of bone Metastases in patients with breast cancer and other solid tumors

被引：37
|
作者：
Lacerna, L [1 ]
Hohneker, J [1 ]
机构：
[1] Novartis Pharmaceut, Med Affairs, E Hanover, NJ 07936 USA
来源：
SEMINARS IN ONCOLOGY | 2003年 / 30卷 / 05期
关键词：
D O I：
10.1053/j.seminoncol.2003.08.017
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：150 / 160
页数：11
相关论文
共 50 条
  • [21] Comparison between zoledronic acid and clodronate in the treatment of prostate cancer patients with bone metastases
    Feng Wang
    Wei Chen
    Hongde Chen
    Licai Mo
    Haiyong Jin
    Zhixian Yu
    Chengdi Li
    Qing Liu
    Feifei Duan
    Zhiliang Weng
    Medical Oncology, 2013, 30
  • [22] Comparison between zoledronic acid and clodronate in the treatment of prostate cancer patients with bone metastases
    Wang, Feng
    Chen, Wei
    Chen, Hongde
    Mo, Licai
    Jin, Haiyong
    Yu, Zhixian
    Li, Chengdi
    Liu, Qing
    Duan, Feifei
    Weng, Zhiliang
    MEDICAL ONCOLOGY, 2013, 30 (03)
  • [23] Renal safety of zoledronic acid in patients with bone metastases from breast cancer (BC) or other tumors treated with IV BisphosphonateS (BPS) for up to ten years
    Guarneri, Valentina
    Donati, Sara
    Nicolini, Massimiliano
    Conte, PierFranco
    ANNALS OF ONCOLOGY, 2004, 15 : 214 - 214
  • [24] Zoledronic Acid Treatment Delays Disease Progression and Improves Survival in Patients With Bone Metastases From Solid Tumors and Elevated Levels of Bone Resorption
    Costa, L.
    Cook, R.
    Body, J.
    Brown, J.
    Terpos, E.
    Saad, F.
    Lipton, A.
    Coleman, R.
    BONE, 2010, 47 : S302 - S303
  • [25] Zoledronic acid in breast cancer patients with bone metastasis
    Halim, I. Abdel
    El Ashry, M.
    El Sherbini, E.
    El Sadda, W.
    EJC SUPPLEMENTS, 2009, 7 (02): : 279 - 280
  • [26] Continuing benefit of zoledronic acid for the prevention of skeletal complications in breast cancer patients with bone metastases
    不详
    BREAST, 2005, 14 : S45 - S46
  • [27] Continuing benefit of zoledronic acid for the prevention of skeletal complications in breast cancer patients with bone metastases
    Rosen, L.
    Gordon, D.
    Chen, Y. M.
    CANCER TREATMENT REVIEWS, 2006, 32 : S43 - S43
  • [28] Zoledronic acid and survival in breast cancer patients with bone Metastases and elevated markers of osteoclast activity
    Lipton, Allan
    Cook, Richard J.
    Major, Pierre
    Smith, Matthew R.
    Coleman, Robert E.
    ONCOLOGIST, 2007, 12 (09): : 1035 - 1043
  • [29] Cost-Effectiveness of Denosumab Compared With Zoledronic Acid in Patients With Breast Cancer and Bone Metastases
    Xie, Jipan
    Diener, Melissa
    Sorg, Rachael
    Wu, Eric Q.
    Namjoshi, Madhav
    CLINICAL BREAST CANCER, 2012, 12 (04) : 247 - 258
  • [30] Continuing benefit of zoledronic acid for the prevention of skeletal complications in breast cancer patients with bone metastases
    不详
    BREAST, 2005, 14 : S44 - S44
12345